Status:
UNKNOWN
AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience
Lead Sponsor:
CareDx
Conditions:
Solid Organ Transplant Rejection
COVID-19
Eligibility:
All Genders
Brief Summary
The utilization of AlloSure to help guide immunosuppression management in solid organ transplant recipients diagnosed with COVID-19
Detailed Description
An observational case series of patients with solid organ transplants who have been admitted with suspected COVID-19 utilizing AlloSure dd-cf DNA to help guide immunosuppression management balancing t...
Eligibility Criteria
Inclusion
- Liver, Heart, Lung or Kidney organ transplant recipient with a suspected or confirmed diagnosis of COVID-19
Exclusion
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04341103
Start Date
April 1 2020
End Date
March 1 2021
Last Update
April 10 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.